Medicare Administrative Contractors, or MACs, are now sporadically reimbursing for Biogen’s expensive new Alzheimer’s drug in limited pockets across the US, as CMS has several months left to finish its decision on national coverage.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,